Table 1 The numbers and relative frequencies of the different AML subtypes within each group of patients
Cohort | TARGET | TCGA | Â | ||||
|---|---|---|---|---|---|---|---|
Group | High (n = 42) | Low (n = 110) | p.value | High (n = 34) | Low (n = 45) | p.value |  |
FAB subtype | |||||||
 M0 | 9.5 | 2.7 | 0.092* | 23.5 | 2.2 | 0.004*** |  |
 M1 | 26.2 | 15.5 | 0.160 | 32.4 | 37.8 | 0.481 |  |
 M2 | 4.8 | 26.4 | 0.003*** | 8.8 | 15.6 | 0.749 |  |
 M4 | 14.3 | 30.0 | 0.061* | 11.8 | 28.9 | 0.097* | p.value |
 M5 | 19.0 | 19.1 | 1 | 14.7 | 15.6 | 1 | * < 0.10 |
 M6 | 0 | 0 | NA | 2.9 | 0 | 0.430 | ** < 0.05 |
 M7 | 2.4 | 0 | 0.276 | 0 | 0 | NA | *** < 0.01 |
 NOS | 14.3 | 0.9 | 0.002*** | 0 | 0 | NA |  |
 unknown | 9.5 | 5.5 | 0.464 | 5.9 | 0 | 0.182 |  |